Micurx Pharmaceuticals

Develops antibiotics against multidrug-resistant (MDR) superbug infections

placeFoster City, California, United States calendar_todayFounded 2007 groups4 employees language micurx.com

Registered entities

Social engagement

Social engagement: 584 social following, 4 posts in the last 12 months — above the industry median.

Investor mix

11 investors on record; lead investors include BioVeda China Fund, Legend Capital.

Investor typeCountShare
Venture capital545%
Private equity327%
Bank & private debt19%
Other / undisclosed218%

Recent activity

5 May 2026
Milestone
revenue
30 Jan 2026
Milestone
regulatory
14 Oct 2025
Event
IDWeek Conference 2025
Coming soon